MedPath

ACCEL-CANDESARTAN/HCTZ

ACCEL-CANDESARTAN/HCTZ

Discontinued
DIN Number

02463865

Drug Class

Human

Market Date

Dec 27, 2017

Company
HC

accel pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02463865
AIG Number0244181001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA06 CANDERSARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification

ACTIVE INGREDIENTS (2)

CANDESARTAN CILEXETILActive
Strength: 16 MG
Monograph: CANDESARTAN CILEXETIL
HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.